Navigation Links
Fewer headaches on the horizon thanks to latest guidelines
Date:1/6/2010

Los Angeles, London, New Delhi, Singapore and Washington DC (Jan 6, 2010) If you're one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That's because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment. The guidelines appear in the latest issue of Cephalalgia (http://cep.sagepub.com/current.dtl#GUIDELINES), now published by SAGE.

Dr Lars Bendtsen and his team from the Clinical Trials Standing Committee of the International Headache Society in Copenhagen, Denmark developed new recommendations on how to improve the quality and safety of the research into treatments for episodic and chronic tension-type headaches. The guidelines will enhance clinical trial safety for patients, and will also allow researchers to determine if older drugs still used to treat tension-type headaches are as effective and safe as they should be.

The last research guidelines for tension-type headache research were published in 1995, but few novel or evidence-based treatment options have become available since that time. Focusing specifically on episodic tension-type headaches (ETTH) and chronic tension-type headaches (CTTH), Bendtsen's goal is to spur new research into the treatment of these commonly occurring headaches. This includes analgesics for episodic headaches as well as preventative treatments for chronic headache sufferers.

Millions of people suffer from ETTH, which can range in frequency from a few times a year to 14 times a month. Many people suffer from CTTH, which can be debilitating. The treatments for these can vary profoundly depending on the severity of the condition.

Over the years, research has found that analgesics - otherwise known as pain-relievers - are usually the most effective way of treating all but the most severe episodic headaches. However, severe episodic headaches and CTTH will often benefit from preventative treatments, which is usually the most effective way of providing lasting relief. Researchers have also found that chronic headache sufferers seldom benefit from analgesics.

Given the many kinds of headache medications available today, and the frequency with which these pain relievers and other treatments are used, new research into tension-related headache treatments will have a great impact on public health. Numerous studies have established that frequent use of analgesics for episodic headaches can increase the risk of side-effects, and can even lead to kidney and liver problems over time. Therefore, identifying more effective treatments for headache sufferers will allow physicians to be more targeted in their choice of drugs. Ultimately, this will translate into a more pain-free life for the tens of millions of people around the world suffering from occasional and chronic tension-type headaches.


'/>"/>

Contact: Mithu Lucraft
mithu.lucraft@sagepub.co.uk
44-207-324-2223
SAGE Publications UK
Source:Eurekalert

Related medicine news :

1. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
2. Fewer adverse cardiac events at one year
3. Hispanics Receive Fewer Surgeries for Vascular Disease
4. Fewer Women Getting Mammograms
5. Fewer Children Outgrowing Allergies to Milk, Eggs
6. Rural Residents Get Fewer Organ Transplants: Study
7. Children who have an active father figure have fewer psychological and behavioral problems
8. Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive
9. Fewer Steps Per Day Send Disease Markers Up
10. Breast Cancer Radiation Therapy Works in Fewer, But Higher Doses
11. Overweight kids have fewer cavities, new study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... Dr. Trevor Gardner, President of ... signed a multifaceted agreement which will allow for the research and development of ... Natural and Applied Sciences, Allied Health and Nursing will work together to develop ...
(Date:4/30/2016)... Santa Rosa, CA (PRWEB) , ... April 30, 2016 , ... “Aging well is a challenge for all of us, ... says NCMA’s Dr. Parul T. Kohli . “Research is showing more and more that ... the risk of disease and disability as we age.” Top priorities Dr. Kohli’s recommends for her ...
(Date:4/29/2016)... ... April 30, 2016 , ... World ... the Pick Up Springboard, an automotive invention that improves the storage features of ... worth $162 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
(Date:4/29/2016)... Fl (PRWEB) , ... April 29, 2016 , ... ... recently notified by the Accreditation Council for Graduate Medical Education (ACGME) that it ... , This is the first accreditation of three residency programs that Memorial is ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016   Click here ... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent ... a definitive agreement to acquire Valley Campus Pharmacy, ... ("TNH"), a leading specialty pharmacy that provides individualized ... California . In 2015, TNH generated approximately ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... , April 28, 2016 ... consumer insights on healthcare, announced today that it has ... report Cool Vendor in Life Sciences, 2016, ... 15, 2016.  The report focuses on life-science- oriented analytics, ... insight from patients and doctors, confirm medication ingestion, and ...
Breaking Medicine Technology: